vs
ANGIODYNAMICS INC（ANGO）与Repay Holdings Corp（RPAY）财务数据对比。点击上方公司名可切换其他公司
ANGIODYNAMICS INC的季度营收约是Repay Holdings Corp的1.0倍（$79.4M vs $78.6M），ANGIODYNAMICS INC净利率更高（-8.0% vs -178.3%，领先170.3%），ANGIODYNAMICS INC同比增速更快（9.0% vs 0.4%），Repay Holdings Corp自由现金流更多（$23.2M vs $4.2M），过去两年ANGIODYNAMICS INC的营收复合增速更高（2.8% vs -1.3%）
AngioDynamics是一家全球医疗技术企业，专注于研发、生产及销售微创医疗设备，核心产品覆盖血管通路、外科消融、肿瘤治疗等领域，面向北美、欧洲、亚太地区的医院、门诊手术中心及各类医疗机构提供服务。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商，为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案，涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具，助力客户简化交易流程、提升运营效率。
ANGO vs RPAY — 直观对比
营收规模更大
ANGO
是对方的1.0倍
$78.6M
营收增速更快
ANGO
高出8.6%
0.4%
净利率更高
ANGO
高出170.3%
-178.3%
自由现金流更多
RPAY
多$19.0M
$4.2M
两年增速更快
ANGO
近两年复合增速
-1.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $79.4M | $78.6M |
| 净利润 | $-6.3M | $-140.1M |
| 毛利率 | 56.4% | 74.2% |
| 营业利润率 | -7.7% | -182.2% |
| 净利率 | -8.0% | -178.3% |
| 营收同比 | 9.0% | 0.4% |
| 净利润同比 | 40.9% | -3304.1% |
| 每股收益（稀释后） | $-0.15 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANGORPAY
| Q4 25 | $79.4M | $78.6M | ||
| Q3 25 | $75.7M | $77.7M | ||
| Q2 25 | $80.2M | $75.6M | ||
| Q1 25 | $72.0M | $77.3M | ||
| Q4 24 | $72.8M | $78.3M | ||
| Q3 24 | $67.5M | $79.1M | ||
| Q2 24 | $71.0M | $74.9M | ||
| Q1 24 | $75.2M | $80.7M |
净利润ANGORPAY
| Q4 25 | $-6.3M | $-140.1M | ||
| Q3 25 | $-10.9M | $-6.4M | ||
| Q2 25 | $-6.0M | $-102.3M | ||
| Q1 25 | $-4.4M | $-7.9M | ||
| Q4 24 | $-10.7M | $-4.1M | ||
| Q3 24 | $-12.8M | $3.2M | ||
| Q2 24 | $-13.4M | $-4.1M | ||
| Q1 24 | $-187.7M | $-5.2M |
毛利率ANGORPAY
| Q4 25 | 56.4% | 74.2% | ||
| Q3 25 | 55.3% | 74.4% | ||
| Q2 25 | 52.7% | 75.7% | ||
| Q1 25 | 54.0% | 75.9% | ||
| Q4 24 | 54.8% | 76.3% | ||
| Q3 24 | 54.4% | 77.8% | ||
| Q2 24 | 54.3% | 78.2% | ||
| Q1 24 | 47.7% | 76.2% |
营业利润率ANGORPAY
| Q4 25 | -7.7% | -182.2% | ||
| Q3 25 | -14.1% | -3.9% | ||
| Q2 25 | -7.2% | -138.7% | ||
| Q1 25 | -13.9% | -4.7% | ||
| Q4 24 | -15.2% | -1.5% | ||
| Q3 24 | -19.4% | -0.9% | ||
| Q2 24 | -20.4% | -4.6% | ||
| Q1 24 | -265.9% | -3.1% |
净利率ANGORPAY
| Q4 25 | -8.0% | -178.3% | ||
| Q3 25 | -14.4% | -8.3% | ||
| Q2 25 | -7.5% | -135.2% | ||
| Q1 25 | -6.1% | -10.3% | ||
| Q4 24 | -14.7% | -5.3% | ||
| Q3 24 | -19.0% | 4.1% | ||
| Q2 24 | -18.9% | -5.4% | ||
| Q1 24 | -249.7% | -6.5% |
每股收益（稀释后）ANGORPAY
| Q4 25 | $-0.15 | $-1.68 | ||
| Q3 25 | $-0.26 | $-0.08 | ||
| Q2 25 | $-0.15 | $-1.15 | ||
| Q1 25 | $-0.11 | $-0.09 | ||
| Q4 24 | $-0.26 | $-0.04 | ||
| Q3 24 | $-0.31 | $0.03 | ||
| Q2 24 | $-0.35 | $-0.04 | ||
| Q1 24 | $-4.67 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.6M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $176.3M | $484.4M |
| 总资产 | $269.7M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势，按日历期对齐
现金及短期投资ANGORPAY
| Q4 25 | $41.6M | $115.7M | ||
| Q3 25 | $38.8M | $95.7M | ||
| Q2 25 | $55.9M | $162.6M | ||
| Q1 25 | $44.8M | $165.5M | ||
| Q4 24 | $54.1M | $189.5M | ||
| Q3 24 | $55.0M | $168.7M | ||
| Q2 24 | $76.1M | $147.1M | ||
| Q1 24 | $78.5M | $128.3M |
总债务ANGORPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | $0 | $435.6M | ||
| Q1 24 | — | $434.9M |
股东权益ANGORPAY
| Q4 25 | $176.3M | $484.4M | ||
| Q3 25 | $178.9M | $616.9M | ||
| Q2 25 | $183.0M | $633.7M | ||
| Q1 25 | $185.9M | $755.7M | ||
| Q4 24 | $186.8M | $761.3M | ||
| Q3 24 | $196.6M | $754.7M | ||
| Q2 24 | $205.6M | $815.4M | ||
| Q1 24 | $218.7M | $813.8M |
总资产ANGORPAY
| Q4 25 | $269.7M | $1.2B | ||
| Q3 25 | $265.6M | $1.3B | ||
| Q2 25 | $280.1M | $1.4B | ||
| Q1 25 | $285.4M | $1.5B | ||
| Q4 24 | $291.6M | $1.6B | ||
| Q3 24 | $293.6M | $1.6B | ||
| Q2 24 | $317.7M | $1.5B | ||
| Q1 24 | $324.8M | $1.5B |
负债/权益比ANGORPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | 0.00× | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.7M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $4.2M | $23.2M |
| 自由现金流率自由现金流/营收 | 5.3% | 29.6% |
| 资本支出强度资本支出/营收 | 0.5% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.3M | $90.7M |
8季度趋势，按日历期对齐
经营现金流ANGORPAY
| Q4 25 | $4.7M | $23.3M | ||
| Q3 25 | $-15.9M | $32.2M | ||
| Q2 25 | $18.8M | $33.1M | ||
| Q1 25 | $-13.2M | $2.5M | ||
| Q4 24 | $2.5M | $34.3M | ||
| Q3 24 | $-18.3M | $60.1M | ||
| Q2 24 | $5.0M | $31.0M | ||
| Q1 24 | $-12.5M | $24.8M |
自由现金流ANGORPAY
| Q4 25 | $4.2M | $23.2M | ||
| Q3 25 | $-16.6M | $32.1M | ||
| Q2 25 | $18.0M | $33.0M | ||
| Q1 25 | $-15.0M | $2.4M | ||
| Q4 24 | $1.7M | $34.0M | ||
| Q3 24 | $-19.3M | $59.8M | ||
| Q2 24 | $4.4M | $30.5M | ||
| Q1 24 | $-13.1M | $24.7M |
自由现金流率ANGORPAY
| Q4 25 | 5.3% | 29.6% | ||
| Q3 25 | -22.0% | 41.3% | ||
| Q2 25 | 22.5% | 43.6% | ||
| Q1 25 | -20.8% | 3.0% | ||
| Q4 24 | 2.3% | 43.5% | ||
| Q3 24 | -28.7% | 75.6% | ||
| Q2 24 | 6.2% | 40.7% | ||
| Q1 24 | -17.5% | 30.6% |
资本支出强度ANGORPAY
| Q4 25 | 0.5% | 0.1% | ||
| Q3 25 | 1.0% | 0.2% | ||
| Q2 25 | 1.0% | 0.1% | ||
| Q1 25 | 2.5% | 0.2% | ||
| Q4 24 | 1.1% | 0.3% | ||
| Q3 24 | 1.6% | 0.3% | ||
| Q2 24 | 0.8% | 0.6% | ||
| Q1 24 | 0.8% | 0.1% |
现金转化率ANGORPAY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANGO
| Med Device | $37.2M | 47% |
| Med Tech | $30.4M | 38% |
| Other | $11.8M | 15% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
